Published online before print September 30, 2002, doi: 10.1161/01.CIR.0000035652.71915.00
(Circulation. 2002;106:2218.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
Allograft Inflammatory Factor-1 Expression Correlates With Cardiac Rejection and Development of Cardiac Allograft Vasculopathy
From the Departments of Physiology (M.V.A., B.A.T.), Cardiology (S.K., E.D.F.), and Pathology (B.I.G.), Cardiovascular Research Group, Temple University School of Medicine, Philadelphia, Pa.
Correspondence to Michael Autieri, PhD, Department of Physiology, Cardiovascular Research Group, Temple University School of Medicine, Room 810, MRB, 3420 N Broad St, Philadelphia, PA 19140. E-mail mautieri{at}unix.temple.edu
Background— Standard morphological features of endomyocardial biopsy specimens do not necessarily correlate with the efficacy of immunotherapy or development of cardiac allograft vasculopathy (CAV). We hypothesized that expression of allograft inflammatory factor-1 (AIF-1), a cytokine-inducible, calcium-binding protein associated with vascular smooth muscle cell proliferation, would be associated with allograft rejection and development of CAV.
Methods and Results— A total of 157 endomyocardial biopsy specimens from 26 patients with heart transplants were examined for expression of AIF-1 mRNA by semiquantitative reverse transcription–polymerase chain reaction. A significant relation was found between the International Society for Heart and Lung Transplantation rejection grade and expression of AIF-1 (P<0.001). The calculated odds ratio indicates that a biopsy has 2.5 times the chance of AIF-1 expression per grade of rejection. The relative concentrations of AIF-1 and GAPDH mRNA were calculated and the resulting ratios indicated that the amount of AIF-1 mRNA expression is relative to the rejection grade (P<0.02). In grade 1 biopsy specimens, AIF-1 was localized to infiltrating immune cells. In grade 3 biopsy specimens, AIF-1 was observed in immune cells and myocytes. AIF-1 is expressed in vascular and immune cells in coronary arteries with CAV, and persistent expression of AIF-1 in the allograft correlates with development of CAV (P<0.002).
Conclusions— Expression of AIF-1 in cardiac allografts correlates with rejection, and the amount of AIF-1 expressed correlates with the severity of rejection. AIF-1 is expressed in coronary arteries with CAV, and persistent expression of AIF-1 in the cardiac allograft is associated with development of CAV.
Key Words: transplantation • restenosis • growth substances • biopsy
This article has been cited by other articles:
 |
|
 |
|
  L. J. Sommerville, S. E. Kelemen, and M. V. Autieri Increased Smooth Muscle Cell Activation and Neointima Formation in Response to Injury in AIF-1 Transgenic Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 47 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Alkassab, P. Gourh, F. K. Tan, T. McNearney, M. Fischbach, C. Ahn, F. C. Arnett, and M. D. Mayes An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis Rheumatology, August 1, 2007; 46(8): 1248 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Litvin, X. Chen, S. Keleman, S. Zhu, and M. Autieri Expression and function of periostin-like factor in vascular smooth muscle cells Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1672 - C1680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hirsch, K. C. Hansen, S. Choi, J. Noh, R. Hirose, J. P. Roberts, M. A. Matthay, A. L. Burlingame, J. J. Maher, and C. U. Niemann Warm Ischemia-induced Alterations in Oxidative and Inflammatory Proteins in Hepatic Kupffer Cells in Rats Mol. Cell. Proteomics, June 1, 2006; 5(6): 979 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tian, S. E. Kelemen, and M. V. Autieri Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1083 - C1091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. F. Yang, D. W. Ho, C. K. Lau, C. T. Lam, C. T. Lum, R. T. P. Poon, and S. T. Fan Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages Int. Immunol., November 1, 2005; 17(11): 1391 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Kelemen and M. V. Autieri Expression of Allograft Inflammatory Factor-1 in T Lymphocytes: A Role in T-Lymphocyte Activation and Proliferative Arteriopathies Am. J. Pathol., August 1, 2005; 167(2): 619 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Chen, S. E. Kelemen, and M. V. Autieri Expression of granulocyte colony-stimulating factor is induced in injured rat carotid arteries and mediates vascular smooth muscle cell migration Am J Physiol Cell Physiol, January 1, 2005; 288(1): C81 - C88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Chen, S. E. Kelemen, and M. V. Autieri AIF-1 Expression Modulates Proliferation of Human Vascular Smooth Muscle Cells by Autocrine Expression of G-CSF Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1217 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Autieri, S. E. Kelemen, and K. W. Wendt AIF-1 Is an Actin-Polymerizing and Rac1-Activating Protein That Promotes Vascular Smooth Muscle Cell Migration Circ. Res., May 30, 2003; 92(10): 1107 - 1114. [Abstract] [Full Text] [PDF]
|
|